Mike Humphries Email

VP, Head US Medical Affairs . AnHeart Therapeutics

Current Roles

Employees:
46
Revenue:
$7.1M
About
AnHeart Therapeutics is an oncology-focused clinical stage biopharmaceutical company headquartered in Hangzhou, China with offices in Beijing, Shanghai and New York. The company’s pipeline consists of three clinical stage assets: Taletrectinib, a next-gen ROS1 and NTRK inhibitor currently in Phase 2; an mIDH1 inhibitor ready for Phase 2 for low grade glioma, cholangiocarcinoma, AML and other tumors; and an AXL inhibitor in Phase 1 for overcoming resistance in various tumors.
AnHeart Therapeutics Address
777 Third Avenue
Shanghai, NY
United States
AnHeart Therapeutics Email

Past Companies

AnHeart TherapeuticsVP, Head of US Medical Affairs
Takeda OncologyHead of Lung Cancer- Global Medical Affairs
Takeda OncologyUS Scientific Director, Lung Cancer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.